$140.64
3.562.60%
At close: -
$140.60
-0.04-0.03%
After Hours: 7:30 PM EDT
Biogen reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Biogen using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-12 | $3.44 | $3.35 | 2.69 % |
Q3 | 2024-10-30 | $4.08 | $3.79 | 7.65 % |
Q2 | 2024-08-01 | $5.28 | $4.02 | 31.3 % |
Q1 | 2024-04-24 | $3.67 | $3.44 | 6.69 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-12 | $2.46B | $2.40B | 2.29 % |
Q3 | 2024-10-30 | $2.47B | $2.43B | 1.48 % |
Q2 | 2024-08-01 | $2.47B | $2.38B | 3.57 % |
Q1 | 2024-04-24 | $2.29B | $2.31B | -0.82 % |
Biogen (BIIB) is scheduled to report earnings on April 23, 2025. The last reported earnings were for reported on February 12, 2025 for Q4.
The Actual EPS was $3.44, which beat the estimate of $3.35.
The Actual Revenue was $2.5B, which beat the estimate of $2.4B.
Browse earnings estimates, EPS, and revenue on all stocks.